EP1226280A4 - Genetic sequences associated with neural cell proliferation and disease - Google Patents

Genetic sequences associated with neural cell proliferation and disease

Info

Publication number
EP1226280A4
EP1226280A4 EP00988496A EP00988496A EP1226280A4 EP 1226280 A4 EP1226280 A4 EP 1226280A4 EP 00988496 A EP00988496 A EP 00988496A EP 00988496 A EP00988496 A EP 00988496A EP 1226280 A4 EP1226280 A4 EP 1226280A4
Authority
EP
European Patent Office
Prior art keywords
disease
cell proliferation
neural cell
sequences associated
genetic sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00988496A
Other languages
German (de)
French (fr)
Other versions
EP1226280A2 (en
Inventor
Joe Z Tsien
Monica Mody
Yanxiang Cao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affymetrix Inc
Princeton University
Original Assignee
Affymetrix Inc
Princeton University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affymetrix Inc, Princeton University filed Critical Affymetrix Inc
Publication of EP1226280A2 publication Critical patent/EP1226280A2/en
Publication of EP1226280A4 publication Critical patent/EP1226280A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP00988496A 1999-10-25 2000-10-25 Genetic sequences associated with neural cell proliferation and disease Withdrawn EP1226280A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16133799P 1999-10-25 1999-10-25
US161337P 1999-10-25
US22763900P 2000-08-24 2000-08-24
US227639P 2000-08-24
PCT/US2000/041515 WO2001030973A2 (en) 1999-10-25 2000-10-25 Genetic sequences associated with neural cell proliferation and disease

Publications (2)

Publication Number Publication Date
EP1226280A2 EP1226280A2 (en) 2002-07-31
EP1226280A4 true EP1226280A4 (en) 2003-10-15

Family

ID=26857750

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00988496A Withdrawn EP1226280A4 (en) 1999-10-25 2000-10-25 Genetic sequences associated with neural cell proliferation and disease

Country Status (4)

Country Link
EP (1) EP1226280A4 (en)
AU (1) AU2470101A (en)
CA (1) CA2389834A1 (en)
WO (1) WO2001030973A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002364889A1 (en) * 2001-09-24 2003-06-10 University Of Aarhus Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
CN101240021B (en) * 2007-12-28 2010-09-08 天津医科大学附属肿瘤医院 Monoclonal antibody for anti-human CDK5RAP2 protein and application thereof
US8396872B2 (en) 2010-05-14 2013-03-12 National Research Council Of Canada Order-preserving clustering data analysis system and method
BR112016016153A2 (en) 2014-01-13 2017-12-12 Berg Llc enolase 1 (eno1) compositions and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997013877A1 (en) * 1995-10-12 1997-04-17 Lynx Therapeutics, Inc. Measurement of gene expression profiles in toxicity determination

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997013877A1 (en) * 1995-10-12 1997-04-17 Lynx Therapeutics, Inc. Measurement of gene expression profiles in toxicity determination

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
"ATLASTM HUMAN CDNA EXPRESSION ARRAY I", CLONTECH, CLONTECHNIQUES, April 1997 (1997-04-01), pages 4 - 7, XP002914393 *
CARULLI JOHN P ET AL: "High throughput analysis of differential gene expression.", JOURNAL OF CELLULAR BIOCHEMISTRY SUPPLEMENT, no. 30-31, 1998, pages 286 - 296, XP002204862, ISSN: 0733-1959 *
CHEN JEREMY J W ET AL: "Profiling expression patterns and isolating differentially expressed genes by cDNA microarray system with colorimetry detection", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 51, no. 3, 1 August 1998 (1998-08-01), pages 313 - 324, XP002159705, ISSN: 0888-7543 *
CIRELLI CHIARA ET AL: "Differences in brain gene expression between sleep and waking as revealed by mRNA differential display and cDNA microarray technology.", JOURNAL OF SLEEP RESEARCH, vol. 8, no. SUPPL. 1, June 1999 (1999-06-01), pages 44 - 52, XP002237949, ISSN: 0962-1105 *
EISEN M B ET AL: "CLUSTER ANALYSIS AND DISPLAY OF GENOME-WIDE EXPRESSION PATTERNS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 95, December 1998 (1998-12-01), pages 14863 - 14868, XP002939285, ISSN: 0027-8424 *
GRAY NATHANAEL S ET AL: "Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.", SCIENCE (WASHINGTON D C), vol. 281, no. 5376, 24 July 1998 (1998-07-24), pages 533 - 538, XP002204861, ISSN: 0036-8075 *
SCHENA M ET AL: "PARALLEL HUMAN GENOME ANALYSIS: MICROARRAY-BASED EXPRESSION MONITORING OF 1000 GENES", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 20, 1 October 1996 (1996-10-01), pages 10614 - 10619, XP002022507, ISSN: 0027-8424 *
See also references of WO0130973A3 *
TAMAYO P ET AL: "INTERPRETING PATTERNS OF GENE EXPRESSION WITH SELF-ORGANIZING MAPS:METHODS AND APPLICATION TO HEMATOPOIETIC DIFFERENTIATION", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 96, March 1999 (1999-03-01), pages 2907 - 2912, XP000942169, ISSN: 0027-8424 *
TORONEN P ET AL: "Analysis of gene expression data using self-organizing maps", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 451, no. 2, 21 May 1999 (1999-05-21), pages 142 - 146, XP004259666, ISSN: 0014-5793 *

Also Published As

Publication number Publication date
EP1226280A2 (en) 2002-07-31
WO2001030973A3 (en) 2001-09-20
CA2389834A1 (en) 2001-05-03
AU2470101A (en) 2001-05-08
WO2001030973A2 (en) 2001-05-03

Similar Documents

Publication Publication Date Title
AU3869400A (en) Human cancer associated gene sequences and polypeptides
AU3997300A (en) Gene sequence variations with utility in determining the treatment of disease
IL137946A0 (en) Intracardiac cell delivery and cell transplantation
EP1142591A4 (en) Gene carriers
EP1077996A4 (en) HUMAN EDG3sb GENE
IL128193A0 (en) Rhamnosyl-transferase gene and uses thereof
EP1222212A4 (en) Il13 mutants
HUP0105208A3 (en) Gene therapy-1
EP1226280A4 (en) Genetic sequences associated with neural cell proliferation and disease
IL146332A0 (en) PrP-LIKE GENE
EP1239039A4 (en) Novel polypeptide and dna thereof
IL147534A0 (en) The il-il1 gene and polypeptide products
AU2153401A (en) Gene expression in biological conditions
HUP0201660A2 (en) Novel polypeptide and dna thereof
HK1043606A1 (en) Plant disease resistance associated genes and uses thereof
AU1894601A (en) Novel gene and use thereof
AU2001290177A1 (en) Immortalized human microglia cell and continuous cell line
GB0025890D0 (en) Gene therapy
GB9713469D0 (en) Neuronal stem cell gene
GB9900009D0 (en) Gene therapy
EP1215284A4 (en) Tsg-like gene
GB9921239D0 (en) Plant resistance gene
GB0406539D0 (en) Gene therapy
EP1182266A4 (en) Cyp2a6 gene judgment methods
GB9908171D0 (en) Gene and use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020522

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12Q 1/68 A

A4 Supplementary search report drawn up and despatched

Effective date: 20030828

17Q First examination report despatched

Effective date: 20031210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040622